fbpx JLABS @ SSF QuickFire Challenge - Challenge | JLABS
JLABS @ SSF QuickFire Challenge

JLABS @ SSF QuickFire Challenge

Challenge ended

Residency at JLABS

Consumer Health
Digital Health


Image paragraph

Ab Initio is applying its proprietary platform to the discovery of protein agents that functionally modulate G protein-coupled receptors, a superfamily of targets key to a wide array of therapeutic indications.

Image paragraph

Chimera develops safe and effective CAR T cell therapeutics, using next generation control technology, against liquid and solid tumors. 

Image paragraph

Precision microbiome engineering company addressing problematic bacteria in agriculture and beyond.

The Challenge

In honor of the Grand Opening of JLABS @South San Francisco, Johnson & Johnson Innovation has launched a quick fire challenge to award up to three new game-changing early-stage innovation companies with the use of a bench and access to the JLABS @South San Francisco community for one year.

We are looking for innovations across pharmaceuticals, medical device & diagnostics and consumer healthcare. Find out more about what areas we desire to explore here.

The winners will not only benefit from world-class lab facilities, but they will also be supported by an onsite team and have access to a global network of industry experts and programming.

Five finalists will present to panel of judges on February 26, 2015. Up to three winners will be announced on Mar 2, 2015 on stage at CALBIO 2015. 

*Certain conditions and restrictions may apply

Rewards and benefits

One Year of Lab Space at JLABS @ South San Francisco


Submission Deadline
Finalist Presentations
Winners Announced at CALBIO 2015

About Johnson & Johnson Innovation

Johnson & Johnson Innovation LLC focuses on accelerating all stages of innovation worldwide and forming collaborations between entrepreneurs and Johnson & Johnson's global healthcare businesses. Johnson & Johnson Innovation provides scientists, entrepreneurs and emerging companies with onestop access to science and technology experts who can facilitate collaborations across the pharmaceutical, medical device and consumer companies of Johnson & Johnson. Under the Johnson & Johnson Innovation umbrella of businesses, we connect with innovators through our regional Innovation Centers, JLABS, Johnson & Johnson Innovation - JJDC, Inc. and our Business Development teams to create customized deals and novel collaborations that speed development of innovations to solve unmet needs in patients. For more information please visit www.jnjinnovation.com.

About Johnson & Johnson Innovation, JLABS

Johnson & Johnson Innovation, JLABS (JLABS) is a global network of open innovation ecosystems, enabling and empowering innovators to create and accelerate the delivery of life-saving, life-enhancing health and wellness solutions to patients around the world. JLABS achieves this by providing the optimal environment for emerging companies to catalyze growth and optimize their research and development by opening them to vital industry connections, delivering entrepreneurial programs and providing a capital-efficient, flexible platform where they can transform the scientific discoveries of today into the breakthrough healthcare solutions of tomorrow.  At JLABS we value great ideas and are passionate about removing obstacles to success to help innovators unleash the potential of their early scientific discoveries.  JLABS is a no-strings-attached model, which means entrepreneurs are free to develop their science while holding on to their intellectual property.  JLABS is open to entrepreneurs across a broad healthcare spectrum including pharmaceutical, medical device, consumer and digital health sectors.

JLABS currently has nine locations in innovation hot spots across North America and produces entrepreneurial programs and campaigns to seek out the best science, like the QuickFire Challenges around the globe. The JLABS flagship opened in 2012 in San Diego at Janssen's West Coast Research Center, and since then, has established two locations in San Francisco - one through a collaboration with the California Institute for Quantitative Biosciences (QB3) and a second standalone facility in South San Francisco.  JLABS is also located in Boston through a collaboration with LabCentral, in Lowell, Massachusetts through a collaboration with UMass, in Houston through a collaboration with the Texas Medical Center (TMC), in Toronto through a collaboration with the Ontario Government and the University of Toronto and a new JLABS @ NYC (in collaboration with the New York Genome Center -opening in 2018).  For more information about JLABS, please visit www.jlabs.jnjinnovation.com.


About BayBio

BayBio brings together the collective strength and experience of the world's most innovative
and productive life science cluster, helping companies grow, connect and advocate to solve some of humanity's most pressing challenges. BayBio provides comprehensive support and solutions tailored to the unique needs of nearly 1000 Bay Area life science companies and institutions, delivering tangible value through group purchasing savings, capital access, government affairs & advocacy, networking and best-practice sharing. BayBio also supports the future of bioscience innovation through the BayBio Institute's work in science education, career development and entrepreneurship. For more information, please visit: https://califesciences.org/.